Literature DB >> 3719915

Morphine depression of myocardial function.

T R Riggs, Y Yano, T Vargish.   

Abstract

A modified Langendorff rat heart preparation with an isolated working rat heart was used to establish the presence of opiate receptors in the myocardium and to demonstrate the effects of an opiate agonist on myocardial function in the absence of neuronal and humoral factors. Twenty-five Sprague-Dawley rats weighing 400-500 gm were anesthetized and had their hearts excised and attached to the Langendorff perfusion apparatus. After a 30 min control period, the Krebs-Henseleit Buffer (KHB) perfusion solution was altered by the addition of 0.9% NaCl (S) or morphine sulfate (MS), which resulted in a final concentration of 2 X 10(-4) M or 3 X 10(-4) M MS in the KHB. Temperature, preload, and afterload were kept constant while heart rate (HR), cardiac output (CO), and aortic dP/dtmax were measured. Significant dose-related depression of HR, CO, and less significantly, aortic dP/dtmax were demonstrated. The data suggest that opiate receptors are present in the myocardium and that morphine sulfate directly effects the myocardium causing a significant decrease in HR, CO, and aortic dP/dtmax. These changes are a result of opiate receptor agonism, which seems to be primarily a negative chronotropic effect and might explain the mechanism for the role of endogenous opiates during shock.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3719915

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  3 in total

1.  Case of morphine-induced ventricular fibrillation.

Authors:  Roman Skulec; Jitka Callerova; Jiri Knor; Petr Ostadal; Petr Kmonicek; Vladimir Cerny
Journal:  World J Emerg Med       Date:  2017

2.  Morphine in acute heart failure.

Authors:  Stefan Agewall
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  Non-invasive continuous cardiac output monitoring in infants with hypoxic ischaemic encephalopathy.

Authors:  Aisling A Garvey; Roisin O'Neill; Vicki Livingstone; Andreea M Pavel; Daragh Finn; Geraldine B Boylan; Deirdre M Murray; Eugene M Dempsey
Journal:  J Perinatol       Date:  2022-09-02       Impact factor: 3.225

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.